Reply to Ward and Colleagues' Comment on "Using Human Experiments of Nature to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors".

Autor: Jerome RN; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA. rebecca.jerome@vumc.org., Pulley JM; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA., Roden DM; Office of Research, Vanderbilt University Medical Center, Nashville, TN, USA., Shirey-Rice JK; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA., Bastarache LA; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, USA., Bernard G; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.; Office of Research, Vanderbilt University Medical Center, Nashville, TN, USA., Ekstrom L; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.; Nashville Biosciences, Nashville, TN, USA., Lancaster WJ; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, USA., Denny JC; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, USA.

Publikováno v: Drug safety [Drug Saf] 2018 Nov; Vol. 41 (11), pp. 1101.

Using Human 'Experiments of Nature' to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors.

Autor: Jerome RN; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA. rebecca.jerome@vumc.org., Pulley JM; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA., Roden DM; Office of Research, Vanderbilt University Medical Center, Nashville, TN, USA., Shirey-Rice JK; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA., Bastarache LA; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, USA., R Bernard G; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.; Office of Research, Vanderbilt University Medical Center, Nashville, TN, USA., B Ekstrom L; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.; Nashville Biosciences, Nashville, TN, USA., Lancaster WJ; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, USA., Denny JC; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, USA.

Publikováno v: Drug safety [Drug Saf] 2018 Mar; Vol. 41 (3), pp. 303-311.

Catheter-directed treatment for acute pulmonary embolism: Systematic review and single-arm meta-analyses.

Autor: Bajaj NS; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA; Department of Epidemiology, Ryals School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA; Division of Cardiovascular Medicine and Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Kalra R; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA; Cardiovascular Division, University of Minnesota, Minneapolis, MN, USA., Arora P; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA., Ather S; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA., Guichard JL; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA., Lancaster WJ; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Patel N; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA., Raman F; University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA., Arora G; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA., Al Solaiman F; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA., Clark DT 3rd; Department of Cardiology, Cleveland Clinic, Cleveland, OH, USA., Dell'Italia LJ; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA; Birmingham Veterans Affairs Medical Center, Birmingham, Alabama, United States., Leesar MA; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA., Davies JE; Division of Cardiothoracic Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA., McGiffin DC; Division of Cardiothoracic Surgery, Department of Surgery, Alfred Hospital and Monash University, Melbourne, Australia., Ahmed MI; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA; Division of Cardiology, Baptist Princeton, Birmingham, Alabama, USA. Electronic address: musiahm@gmail.com.

Publikováno v: International journal of cardiology [Int J Cardiol] 2016 Dec 15; Vol. 225, pp. 128-139. Date of Electronic Publication: 2016 Sep 20.

Adverse drug reactions. A review and suggested reporting program.

Autor: Lancaster WJ

Publikováno v: American journal of hospital pharmacy [Am J Hosp Pharm] 1965 Sep; Vol. 22 (9), pp. 524-31.